Tysabri (natalizumab) is a brand-name intravenous (IV) infusion. It’s prescribed for adults with Crohn’s disease or certain forms of multiple sclerosis. Tysabri has interactions with some ...

Regulators in the US and Europe have started to review Novartis' biosimilar version of Biogen's big-selling multiple sclerosis therapy Tysabri, which could reach the market next year. If approved ...

Sandoz and Polpharma Biologics have become the first companies to get FDA approval for a biosimilar of Biogen's blockbuster multiple sclerosis therapy Tysabri, after overcoming a bid by Biogen to ...

As temperatures rise in Metro Manila, the Japan Travel Fair 2025 is set to offer a refreshing escape for Filipinos eager to discover the wonders of Japan. On February 22 and 23, the Glorietta ...

Digital technologies offer significant advantages for industry; however, increased connectivity and reliance on data can expose organizations to cyber threats. Incidents such as data breaches, ...

Multiple sclerosis (MS) and other conditions affecting the immune system can activate the John Cunningham (JC) virus, causing a potentially life threatening infection. The JC virus is common, and ...

Sales of Biogen’s MS drugs like Tecfidera and Tysabri are likely to have declined amid rising competitive pressure in the market. Tecfidera sales have been declining as multiple generic versions ...